Clinical Trial Update: A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical study evaluating universal CD19/CD20 CAR-T cell therapy for safety and potential efficacy in moderate to severe refractory systemic lupus e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• universal CD19/CD20 CAR-T cell injection (CD19/CD20 CAR-T cells)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Systemic Lupus Erythematosus (SLE) | EARLY_Phase 1 | Status: RECRUITING